Litcius/Paper detail

Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis

Ying Dong, Bixi Tang, Qi Wang, Li‐Wei Zhou, Cong Li, Xuan Zhang, Dandan Sun, Xin Sun, Xuemei Zhang, Bing Xiong, Jia Li, Hong Shi, Dan-Qi Chen, Yi Zang

2021Acta Pharmacologica Sinica16 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePulmonary fibrosisIdiopathic pulmonary fibrosisPharmacologyKinaseFibrosisCancer researchInternal medicineChemistryLungBiochemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Myeloid Leukemia TreatmentsMast cells and histamine
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis | Litcius